2.6
2023

Online first abstracts

    05/05/2025
    Letter to the Editor

    Is Tezepelumab the treatment option of choice in severe allergic asthma?

    Alessandro Maria Marra alessandromarra@hotmail.com1, Benedetta Biagioni2, Francesco Bini1, Lorenzo Cecchi2
    See More
    05/05/2025
    Letter to the Editor

    Redefining reference intervals for baseline serum tryptase: found the solution?

    Danilo Villalta danilo.villalta@asfo.sanita.fvg.it1, Mariaelisabetta Conte1, Daniela Visentini2, Matteo Furlani3, Francesco Ellero3, Roberta Metani3, Fiorenza Pesente2, Paolo Metus4
    See More
    30/04/2025
    Letter to the Editor

    Delayed pressure urticaria affects chronic spontaneous urticaria treatment response: CURE insights

    Daria Fomina konovaolly@mail.ru1,2,3, Elena Kovalkova1, Marcus Maurer4,5†
    See More
    30/04/2025
    Letter to the Editor

    Selective hypersensitivity to metamizole: role of specific IgE in the evaluation of immediate reactions

    Josefina Vieira josefinavieira93@live.com.pt1,2, Sofia Cosme Ferreira1,2, Diana F. Santos3,4, Marisa Paulino2, Susana L. Silva2,3,5
    See More
    29/04/2025
    Original Article

    Anaphylaxis trend before and during pandemic: COVID-19 did not affect anaphylaxis frequen-cy

    Andrea Sangalli andrea.sangalli@unimi.it1, Annalaura Fasiello1, Valerio Pravettoni2, Dario Consonni3, Valerie Melli2, Alessandro Jachetti4, Valentina Longo1, Nicola Montano2,5, Federica Rivolta2
    See More
    29/04/2025
    Original Article

    The 2-week time interval criterion may alter the spectrum of disease and patient characteristics in children diagnosed with hypereosinophilia

    Ibrahim Cemal Maslak icmaslak@gmail.com
    See More
    1 2 3 4 5 6 … 12

Contact

EDRA SPA

Viale Enrico Forlanini 21
20134 Milan, Italy

WWW.EDRASPA.IT

FOLLOW US
European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024